Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)-Reference-Cited by-同舟云学术

Using Whole Genome Amplification (WGA) of Low-Volume Biopsies to Assess the Prognostic Role of EGFR, KRAS, p53, and CMET Mutations in Advanced-Stage Non-small Cell Lung Cancer (NSCLC)

Published:2009-01 Issue:1 Volume:4 Page:12-21
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Lim Elaine H.,Zhang Shen-Li,Li Jia-Liang,Yap Wee-See,Howe Tse-Chiang,Tan Bien-Peng,Lee Yong-Shyan,Wong Daniel,Khoo Kay-Leong,Seto Kar-Yin,Tan Lenny,Agasthian Thirugananam,Koong Heng-Nung,Tam John,Tan Christie,Caleb Michael,Chang Alex,Ng Alan,Tan Patrick

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference46 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. The IASLC lung cancer staging project: proposals for the revision of the tnm stage groupings in the forthcoming (7th) edition of the TNM Classification of malignant tumours;Goldstraw;J Thorac Oncol,2007

3. Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced non-small cell lung cancer;Shih;Int J Cancer,2006

4. Mutations in the epidermal growth factor receptor and KRAS are predictive and prognostic indicators in patients with non-small cell lung cancer treated with chemotherapy alone and in combination with erlotinib;Eberhard;J Clin Oncol,2005

5. Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers;Lim;Clin Cancer Res,2003

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electrochemical biosensors for determination of tumor biomarkers;Semiconducting Polymer Materials for Biosensing Applications;2024

2. FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner;Cell Death & Disease;2023-08-26

3. Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers;iScience;2023-07

4. PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC;Cancers;2023-07-01

5. FSP1 and NRF2 independently contribute to ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma;2023-05-17